Verastem (VSTM) Net Cash Flow (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -158.62% |
| Dec 31, 2025 | 466.93% |
| Sep 30, 2025 | -139.22% |
| Jun 30, 2025 | 62.61% |
| Mar 31, 2025 | 218.04% |
| Dec 31, 2024 | -181.72% |
| Sep 30, 2024 | 2,827.70% |
| Jun 30, 2024 | -71.06% |
| Mar 31, 2024 | 119.89% |
| Dec 31, 2023 | 79.80% |
| Sep 30, 2023 | -202.32% |
| Jun 30, 2023 | 272.72% |
| Mar 31, 2023 | 739.38% |
| Dec 31, 2022 | -123.64% |
| Sep 30, 2022 | -12.01% |
| Jun 30, 2022 | -32.13% |
| Mar 31, 2022 | 930.67% |
| Dec 31, 2021 | -365.35% |
| Sep 30, 2021 | 93.76% |
| Jun 30, 2021 | 67.33% |
| Mar 31, 2021 | 76.56% |
| Dec 31, 2020 | -406.81% |
| Sep 30, 2020 | 553.50% |
| Jun 30, 2020 | -110.82% |
| Mar 31, 2020 | 468.84% |
| Dec 31, 2019 | -154.09% |
| Sep 30, 2019 | -145.28% |
| Jun 30, 2019 | 156.22% |
| Mar 31, 2019 | -7,245.21% |
| Dec 31, 2018 | 98.63% |
| Sep 30, 2018 | -136.34% |
| Jun 30, 2018 | 689.60% |
| Mar 31, 2018 | -157.34% |
| Dec 31, 2017 | 30.48% |
| Sep 30, 2017 | 4,074.33% |
| Jun 30, 2017 | 85.71% |
| Mar 31, 2017 | 16.03% |
| Dec 31, 2016 | -116.86% |
| Sep 30, 2016 | -109.38% |
| Jun 30, 2016 | 351.13% |
| Mar 31, 2016 | -292.95% |
| Dec 31, 2015 | 132.85% |
| Sep 30, 2015 | -403.96% |
| Jun 30, 2015 | 233.66% |
| Mar 31, 2015 | -128.30% |
| Dec 31, 2014 | 827.59% |
| Sep 30, 2014 | -120.05% |
| Jun 30, 2014 | 262.04% |
| Mar 31, 2014 | -50.49% |
| Dec 31, 2013 | -142.82% |
| Sep 30, 2013 | 160.98% |
| Jun 30, 2013 | -179.15% |
| Mar 31, 2013 | 1,862.04% |
| Dec 31, 2012 | 77.73% |
| Sep 30, 2012 | 52.41% |
| Jun 30, 2012 | -315.21% |
| Mar 31, 2012 | 122.06% |
| Dec 31, 2011 | -175.07% |
| Sep 30, 2011 | 138.35% |
| Jun 30, 2011 | 1,419.38% |